Accès à distance ? S'identifier sur le proxy UCLouvain
Continuous improvement versus innovation : the case for sipuleucel-T.
Primary tabs
Tombal, Bertrand
[UCL]
| Document type | Article de périodique (Journal article) – Éditorial |
|---|---|
| Access type | Accès restreint |
| Publication date | 2012 |
| Language | Anglais |
| Journal information | "European Urology" - Vol. 61, no. 4, p. 648-649; discussion 650-651 (2012) |
| Publisher | Elsevier BV ((Netherlands) Amsterdam) |
| issn | 0302-2838 |
| e-issn | 1421-993X |
| Publication status | Publié |
| Affiliations |
UCL
- (SLuc) Service d'urologie UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation |
| MESH Subject | Antineoplastic Agents, Hormonal - therapeutic use ; Cancer Vaccines - therapeutic use ; Drug Resistance, Neoplasm ; Humans ; Male ; Prostatic Neoplasms - drug therapy ; Tissue Extracts - therapeutic use |
| Links |
| Bibliographic reference | Tombal, Bertrand. Continuous improvement versus innovation. In: European Urology, Vol. 61, no. 4, p. 648-649; discussion 650-651 (2012) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/112086 |